secwatch / observer
APRE Aprea Therapeutics, Inc.
CIK 0001781983 showing 1 recent 8-K latest May 13, 2026 10:35 UTC

Recent 8-K filings for APRE

Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.

source · APRE on sec.gov